Drugs / Hemospray
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02537353 Comparator | Sep 2015 → Jul 2017 | — | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hemospray | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02537353 ↗ |
| Modality | Other / unclassified | “This new technology consists of a syringe containing the Hemospray ® powder, inorganic property comprises a group of minerals” NCT02537353 ↗ |
| Route | Other | “The powder is sprayed by means of a catheter connected to a container of carbon dioxide.” NCT02537353 ↗ |